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Available online xxxxTo elucidate the function of a gene in bacteria it is vital that targeted gene inactivation (allelic replacement) can
be achieved. Allelic replacement is often carried out by disruption of the gene of interest by insertion of an anti-
biotic-resistancemarker followedby subsequent transfer of themutant allele to the genomeof the host organism
in place of the wild-type gene. However, due to their intrinsic resistance to many antibiotics only selected anti-
biotic-resistance markers can be used in members of the genus Burkholderia, including the Burkholderia cepacia
complex (Bcc). Here we describe the construction of improved antibiotic-resistance cassettes that specify resis-
tance to kanamycin, chloramphenicol or trimethoprim effectively in the Bcc and related species. Thesewere then
used in combinationwith and/or to construct a series enhanced suicide vectors, pSHAFT2, pSHAFT3 and pSHAFT-
GFP to facilitate effective allelic replacement in the Bcc. Validation of these improved suicide vectorswas demon-
strated by the genetic inactivation of selected genes in the Bcc species Burkholderia cenocepacia and B. lata, and in
the non-Bcc species, B. thailandensis.







Burkholderia cepacia complex (Bcc) are a group of at least twenty
closely related Gram-negative bacterial species of the Burkholderia
genus, which are phenotypically similar but genetically different
(Vandamme et al., 1997; De Smet et al., 2015). These species are
found ubiquitously in the environment, including soil, water and the
rhizosphere of some plants (Coenye and Vandamme, 2003). Many Bcc
species have also been isolated from the sputum of cystic-ﬁbrosis (CF)
patients, identifying them as opportunistic pathogens of those with
lung disease and weakened immune systems (Henry et al., 1997;
Speert et al., 2002). Colonisation of the lungs by Bcc can result in several
clinical outcomes, including chronic-infection with gradual lung deteri-
oration and a rare adverse reaction known as cepacia syndrome, which
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lasmid.2016.11.002often fatal (Isles et al., 1984). The most prevalent causative agents of
Bcc infections in CF-patients in the UK, Canada and USA are B.
cenocepacia and B. multivorans (Drevinek and Mahenthiralingam,
2010; De Soyza et al., 2010; Zlosnik et al., 2015). Unfortunately, Bcc in-
fections can be difﬁcult to treat due to the high intrinsic resistance of
these bacteria to many antibiotics. Over recent years restrictions have
been placed on individuals colonized with Bcc to prevent transmission
of Bcc infections, by limiting their contact with at risk members of the
population (Ledson et al., 1998).
Efforts have been made to understand the virulence mechanisms
used by Bcc bacteria that allow them to be successful pathogens.
These include mechanisms of bacterial cell invasion, intracellular sur-
vival, quorum sensing, iron acquisition, and protein secretion (Martin
and Mohr, 2000; Sokol et al., 2003; Visser et al., 2004; Mullen et al.,
2007; Aubert et al., 2008; Uehlinger et al., 2009; Somvanshi et al.,
2010). A key factor to aid in the characterization of these traits is the
ability to manipulate the genome of Bcc species. Methods for targeted
gene inactivation in Burkholderia have largely relied on the disruption
of the target chromosomal gene with an antibiotic-resistance marker,
either through employing an integrative vector (Flannagan et al.,
2007; Chapalain et al., 2013) or by allelic replacement whereby the
wild type gene is replaced by a copy of the target gene that is inactivated
with an antibiotic-resistance cassette (Huber et al., 2001; Malott et al.,
2005; Agnoli et al., 2006). In the latter, two recombination crossover
events are selected for (one occurring either side of the lesion in the tar-
get gene) and no vector sequences remain on the chromosome in thethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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mids in the pEX18 and pEX19 series (Hoang et al., 1998), and a vector
constructed in our lab, pSHAFT (Agnoli et al., 2006).
Due to their high level of intrinsic resistance to many antibiotics, the
number of commonly employed resistancemarkers that can be used for
geneticmanipulation of Bcc species is generally restricted to those spec-
ifying increased resistance to trimethoprim, chloramphenicol and tetra-
cycline. All three markers can be selected for in single copy in B.
cenocepacia (Farmer and Thomas, 2004; Asghar et al., 2011; Ryan et
al., 2013). For aminoglycoside-sensitive strains, whether naturally oc-
curring (such as B. cenocepacia strain H111) or engineered, the aac
and aph markers, which specify resistance to the aminoglycosides
gentamycin and kanamycin, respectively, are selectable in single copy
and can therefore also be used in allelic replacement experiments
(Huber et al., 2001; Hamad et al., 2010; Inhülsen et al., 2012; Carlier et
al., 2014).
Allelic replacement in bacteria involving disruption of a target gene
with a selectable resistancemarker can be problematic if the host bacte-
rium already exhibits a high degree of intrinsic resistance to the antibi-
otic, thereby precluding selection of themarker. This can be ameliorated
if the antibiotic-resistance gene is efﬁciently expressed. However, the
use of strong promoters to drive high-level transcription of the marker
gene can exert detrimental polar effects that include destabilisation of
plasmids housing such markers or unwanted or toxic expression of
downstream genes following insertion of the marker in the host ge-
nome (Stueber and Bujard, 1982; Stassi and Lacks, 1982; Schrecke et
al., 2013; our published observations). In these situations the negative
effects of very active promoters can be circumvented by placement of
a strong transcription terminator downstream of the selectable marker
gene (Gentz et al., 1981; Fellay et al., 1987). Here we describe the con-
struction of novel antibiotic-resistance cassettes where we have
employed these principles either to increase expression of the antibiot-
ic-resistance marker to facilitate its selection in a single copy or to pre-
vent detrimental polar effects by blocking transcriptional read through
into downstream genes. These cassettes were used to build improved
suicide vectors derived from the vector pSHAFT and were also used in
conjunction with these vectors for allelic replacement in the Bcc and
other members of the genus Burkholderia.
2. Materials and methods
2.1. Strains, plasmids, and growth conditions
The bacterial strains and plasmids used in this study are given in
Supplementary Table S1. For cultivation of bacteria, strains were rou-
tinely grown in/on LB medium at 37 °C. For selection of trimethoprim
resistance in E. coli isosensitest agar (Oxoid) was employed, whereas
for B. cenocepacia M9-minimal salts agar containing 0.5% glucose was
used (except where indicated). M9-minimal salts used here contained
42 mM Na2HPO4, 22 mM KH2PO4, 19 mM NH4Cl, 9 mM NaCl, 1 mM
MgSO4 and 100 μM CaCl2. For selection of kanamycin resistance in B.
cenocepacia Lennox agar was utilised. Antibiotics were used, when ap-
propriate, at the following concentrations for selection of plasmids
and antibiotic-resistance cassettes in E. coli and Burkholderia species,
as indicated: ampicillin, 100 μg/ml (E. coli); kanamycin, 50 μg/ml (E.
coli and B. cenocepacia); chloramphenicol, 25 μg/ml (E. coli) and 50 μg/
ml (B. cenocepacia); trimethoprim, 25 μg/ml (E. coli, B. cenocepacia and
B. lata) and 50 μg/ml (B. thailandensis). For B. cenocepacia strains
exhibiting a high intrinsic resistance to trimethoprim, such as K56-2,
this antibiotic was included in the medium at 100 μg/ml.
2.2. DNA preparation and manipulation
Recombinant DNA techniques were performed essentially as de-
scribed in Sambrook et al. (1989). DNA ampliﬁcation by PCR was per-
formed as standard according to the manufacturer's instructions usingPlease cite this article as: Shastri, S., et al., An efﬁcient system for the genera
Plasmid (2016), http://dx.doi.org/10.1016/j.plasmid.2016.11.002KOD DNA polymerase enzyme (Millipore) and a G-storm thermocycler.
Primers used in this study are indicated in Supplementary table S2, and
were purchased from Eurogentec, Belgium. To extract DNA for PCR, bac-
terial colonies were resuspended in 200 μl TE buffer (10 mM Tris,
1.0 mM EDTA (pH 8.0)), boiled for 7 min, and then centrifuged to pellet
cell debris. The supernatant was retained for use in PCR (referred to as
‘boiled lysate’). PCR products were puriﬁed from solution or by agarose
gel-extraction using a QIAquick PCR puriﬁcation kit (Qiagen). DNA re-
striction enzymes were purchased from Promega or New England
Biolabs. DNA was ligated using T4 DNA ligase (Promega). 5′ DNA over-
hangs were ﬁlled-in using DNA I polymerase Klenow fragment
(Promega). Sequencing was performed by the Core Genomic Facility
at The University of Shefﬁeld, UK.
2.3. Plasmid constructions
Plasmids were extracted from saturated bacterial cultures using
a spin-column-based plasmid mini-prep extraction kit (Thermo
Scientiﬁc). Plasmids were transferred into E. coli by heat‐shock assisted
transformation according to Hanahan (1983).
To construct p34E-Km, the Tn5-derived aphA2 gene, including its
promoter (Rothstein and Reznikoff, 1981), was excised from pKNOCK-
Km as aMluI fragment, end-ﬁlled with DNA polymerase I Klenow frag-
ment and ligated between the ﬁlled EcoRI sites of p34E-Tp.
To generate p34E-Cm2, the catA2 gene of the plasmid pSHAFT was
ampliﬁed with primers p34E-Cmfor2 and p34E-Cmrev, which incorpo-
rated a synthetic promoter (−10 and−35 elements) upstream of the
catA2 TIR in the ampliﬁed product. The 823 bp amplicon was restricted
with EcoRI and used to replace the EcoRI-excised KmR cassette of p34E-
Km.
To construct p34E-TpTer, ﬁrst a 306 bpDNA fragment containing the
rrnB T1 T2 terminators was ampliﬁed from the plasmid pEA302T with
rrnBterfor and rrnBterrev and restrictedwith BamHI andHindIII, follow-
ing which it was ligated between the corresponding restriction sites of
pUC18 to give pUC18Ter. Second, the megaprimer variation of SOE
PCR (Perrin and Gilliland, 1990) was used to fuse the rrnB T1 T2 termi-
nators to the 3′ end of dfrB2. To do this, the dfrB2 gene (and native pro-
moter) was ampliﬁed from p34E-Tp with primer Tp(forward), and the
fusion primer Tp(reverse) that was complementary to the 3′ end of
the dfrB2 gene, including the stop codon, and contained a 5′ tail with
19 bp of homology to the upstream region of the rrnB T1 T2 DNA frag-
ment. The resultant amplicon served as a forward megaprimer in com-
bination with reverse primer rrn(R), to amplify a 903 bp dfrB2-rrnB
T1BT2 fusion fragment from pUC18Ter. This product was then ligated
between the EcoRI andHindIII sites of pUC19, giving rise to pUC19TpTer.
Last, the TpTer cassette of pUC19TpTer was excised as a StuI fragment
and ligated between the ﬁlled-in EcoRI sites of p34E-Km, thereby re-
placing the KmR cassette.
To construct pSHAFT2, the catA2 region of pSHAFT was ampliﬁed
with a pair of primers, pSHOOTERfor2 and pSHOOTERrev. The 871 bp
product was digested with BamHI and SalI and ligated between the
BglII and SalI sites of pSHAFT, thereby replacing the Ω-Cm interposon.
To construct pSHAFT3, ﬁrst, a double-stranded oligonucleotide was
generated by annealing oligonucleotides pSHAFT3MCSfor and
pSHAFT3MCSrev. This was achieved by combining 45 μM of each oligo-
nucleotide in 1× KOD DNA polymerase reaction buffer (Millipore) and
1 mMMgCl2, incubating at 90 °C for 10 min followed by incubation at
room temperature for 1 h and subsequent puriﬁcation of the double-
stranded oligonucleotide. pSHAFT2 was restricted with NotI and EcoRI
and ligated to the double-stranded oligonucleotide, to generate
pSHAFT3.
To construct pSHAFT-GFP, an 866 bp DNA fragment containing the
gfp coding sequence and Shine-Dalgarno was ampliﬁed from pBHR1-
GFP with primers GFPfor and GFPrev, puriﬁed and digested with
BamHI and SalI. This was then ligated between BglII-SalI sites of pSHAFT
to replace the 3.7 kbΩ-Cm fragment of this vector.tion ofmarked geneticmutants inmembers of the genus Burkholderia,
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pSHAFT2, pSHAFT3 and pSHAFT-GFP were deposited in GenBank da-
tabase, and given the accession numbers KX485327, KX485328,
KX485329, KX485330, KX485332, KX485333 and KX485331, respec-
tively. As we observed that the nucleotide sequence of the dfrB2 cas-
sette in p34E-Tp as deposited in the database is incorrect, we have
also submitted an amended sequence of this plasmid that has been
assigned accession number KX485326. pUC18Ter and pUC19TpTer
were assigned accession numbers KX527623 and KX527624,
respectively.2.4. Gene replacement in B. cenocepacia
To inactivate chromosomal genes in Burkholderia using pSHAFT2
or pSHAFT3, the antibiotic counter-selection-based strategy used for
allelic replacement by pSHAFT was employed (Agnoli et al., 2006).
For isolation of a B. cenocepacia BCAM0195::Tp mutant, a 3.64 kb
DNA fragment containing the BCAM0195 gene orthologue in strain
H111was ampliﬁed from a boiled lysate using primers BCAM0195for
and BCAM0195rev, restricted with HindIII and BamHI and ligated be-
tween the corresponding sites of pBBR1MCS-1, generating pBBR1-
BCAM0195’. The cloned 3.11 kb gene fragment was then disrupted
by ligation of the p34E-Tp-derived TpR cassette as a SmaI-fragment
between two PmlI sites located 1.58 kb apart within BCAM0195, gen-
erating pBBR1-ΔBCAM0195'::Tp. The 2.04 kb ΔBCAM0195'::Tp allele
was transferred to pSHAFT2 as a XhoI-XbaI fragment to give
pSHAFT2-ΔBCAM0195'::Tp. This plasmid was conjugated into B.
cenocepacia H111 using E. coli donor strain S17-1(λpir) according
to Herrero et al. (1990) and de Lorenzo and Timmis (1994), and B.
cenocepacia were selected on M9-glucose agar containing trimetho-
prim. Exconjugants were patched onto the samemedium and also LB
agar containing chloramphenicol. Exconjugants that were chloram-
phenicol-sensitive were identiﬁed as candidate ΔBCAM0195::Tp
mutants. Due to the loss of short regions of DNA at the 5′ and 3′
ends of BCAM0195 during the construction of pSHAFT2-
ΔBCAM0195'::Tp, potential ΔBCAM0195::Tp mutants could be veri-
ﬁed by PCR using the original BCAM0195for and BCAM0195rev
primers, as they annealed to genomic sequences located a short dis-
tance either side of the region of DNA that was also present in
pSHAFT2-ΔBCAM0195'::Tp.
For isolation of a BCAL1709::TpTer mutant in B. cenocepacia AHA27,
a 1.354 kb DNA fragment containing the 3′ region of the BCAL1709
orthologue was ampliﬁed from B. cenocepacia Pc715j genomic DNA
using primers BCAL1709for and BCAL1709rev, restricted with XbaI and
XhoI, and the resulting 1.297 kb amplicon was ligated between the cor-
responding sites of pSHAFT-GFP to give rise to pSHAFT-GFP-BCAL1709.
The BCAL1709 gene was then disrupted by ligation of the p34E-TpTer-
derived TpR cassette as a SmaI fragment into a unique ZraI site within
BCAL1709, resulting in pSHAFT-GFP-BCAL1709::TpTer. This plasmid
was then conjugated into AHA27 and exconjugants containing the
BCAL1709::TpTer allele within the genome were selected for as de-
scribed for construction of the BCAM0195::Tp mutant. The presence of
gfp on pSHAFT-GFP causes recipient colonies to ﬂuoresce under UV
light, and was used to distinguish between recombinants that arose
through a single crossover (i.e. plasmid integration - ﬂuorescent) and
a double crossover (i.e. allelic replacement - non-ﬂuorescent). 50 tri-
methoprim-resistant exconjugants were patched on duplicate IST
agar plates containing trimethoprim. One of each pair of plates was
exposed to UV light on a transilluminator in the dark to identify
non-ﬂuorescent candidate AHA27 BCA1709::TpTer mutants. Candi-
date mutants from the non-irradiated duplicate plate(s) were veri-
ﬁed by PCR using primers BCAL1709forOut and BCAL1709revOut,
which annealed to genomic sequences a short distance either
side of the region of DNA that was also present in pSHAFT-GFP-
BCAL1709::TpTer.Please cite this article as: Shastri, S., et al., An efﬁcient system for the genera
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3.1. Construction of antibiotic resistance cassettes for genetic manipulation
of Burkholderia
To facilitate the generation ofmutants in Burkholderia through inser-
tional inactivation of chromosomal target genes by antibiotic resistance
markers and the construction of useful plasmid vectors that would
allow an investigation into gene function and control in members of
this genus, we made derivatives of the cassette cloning vector, p34E
(Tsang et al., 1991), harbouring the kanamycin- (aphA2), chloramphen-
icol- (catA2) and trimethoprim- (dfrB2), resistance genes.
First, p34E-Km was constructed by replacing the trimethoprim-re-
sistance (TpR) cassette of p34E-Tp with the Tn5-derived aphA2
(aph(3′)-II) gene from pKNOCK-Km (Fig. 1). Although a similar kana-
mycin-resistance cassette (KmR) plasmid, p34S-Km (which contains
the Tn903-derived aph(3′)-Ia gene), has been previously described
(Dennis and Zylstra, 1998a), the Tn5-derived antibiotic resistance
marker in p34E-Km offers the advantage that it makes available the
HindIII and SmaI sites ﬂanking the cassette (as they do not cut within
the aphA2 gene) and also containsﬂanking EcoRI sites. Both types of cas-
sette are of a similar size (~1.3 kb). A shorter variant of the Tn903-based
KmR cassette lacking the internalHindIII and SmaI siteswas subsequent-
ly constructed, but it lacks the ﬂanking EcoRI sites and the possibility for
directional cloning associated with p34E-Km (Dennis and Zylstra,
1998b).
Most plasmids used for genetic manipulation that specify chloram-
phenicol resistance (CmR) harbour the Tn9-derived catA1 gene (or one
that is closely related) that speciﬁes an enzyme belonging to group 1
of the type A chloramphenicol acetyltransferases (CATs) (Shaw, 1983;
Schwarz et al., 2004). A notable exception is mini-Tn5Cm, which con-
tains the catA2 gene (de Lorenzo et al., 1990). Pertinently, chloramphen-
icol resistance conferred by this mini-transposon is selectable in single
copy in B. cenocepacia (Farmer and Thomas, 2004). However, the
catA2 gene specifying this resistance is located on a large DNA fragment
(the ~3.7 kbΩ-Cm interposon) that was used to assemble the transpo-
son and is not available as a small cassette (Fellay et al., 1987; de
Lorenzo et al., 1990). TheΩ-Cm interposon includes a 2.8 kb DNA frag-
ment derived from the cloning vector pKT210 which contains the 214
codon catA2ORF and several other predicted ORFs found on the natural-
ly occurring BHR plasmid pSa (Bagdasarian et al., 1981; Tait et al., 1982;
Shaw, 1983; Fellay et al., 1987). In order to generate a compact CmR cas-
sette containing an efﬁciently expressed cat gene, the catA2 gene
contained on pSHAFT (a suicide plasmid derived from pUTmini-
Tn5Cm (see below)), was modiﬁed to incorporate a synthetic σ70-de-
pendent promoter upstream of the catA2 TIR. The modiﬁed catA2 gene
was used to replace the KmR cassette of p34E-Km, to generate p34E-
Cm2 (Fig. 1). The CmR cassette in p34E-Cm2, can be transferred to
other vectors using any of the ﬂanking restriction sites except SmaI
(Fig. 1), although even here, selection for chloramphenicol resistance
would permit selection for the products of a tripartite ligation between
the target vector and the two SmaI-generated cassette fragments. As an
alternative, either of the blunt end-generating SacI isoschizomers,
Eco53kI or Ecl136II, may be used.
The most similar vectors available as sources of a CmR cassette are
p34S-Cm and -Cm2 (Dennis and Zylstra, 1998a, 1998b). Rather than
the catA2 gene present in p34E-Cm2, these other plasmids contain the
Tn9-derived catA1 gene and the cassettes are slightly longer (918 bp
rather than 823 bp). p34S-Cm contains an internal EcoRI site whereas
in p34S-Cm2 this site has been removed. However, unlike p34E-Cm2,
p34S-Cm2 lacks ﬂanking EcoRI sites.
The trimethoprim-resistance gene (dfrB2) present on the cassette
vectors p34E-Tp and p34S-Tp is under control of the very strong
PcS integron promoter (also known as P1) (Lévesque et al., 1994;
DeShazer and Woods, 1996; Dennis and Zylstra, 1998a; Jové et al.,
2010). We have observed that insertion of the TpR cassette in certaintion ofmarked geneticmutants inmembers of the genus Burkholderia,
Fig. 1.Maps of novel antibiotic-cassette vectors. The location of antibiotic resistance-conferring genes, bla (ampicillin-resistance), aphA2 (kanamycin-resistance), catA2 (chloramphenicol-
resistance) and dfrB2 (trimethoprim-resistance), and the plasmid ColE1 origin of replication (oriR) are indicated for plasmids p34E-Km (top), p34E-Cm2 (left) and p34E-TpTer. Dual-
cutting restriction sites that can be utilised to excise the antibiotic resistance cassette are also shown, as are internal sites that can be used for determination of the orientation of the
cassette following insertion into a target gene. Restriction sites that occur only once in each plasmid are shown in bold. Note that additional sites for AseI, BsrGI, NheI and XmnI occur in
the backbone of all three vectors that for clarity are not shown. Promoters for the cassette antibiotic-resistance genes are shown (Paph, Pcat, PcS). Maps created with SnapGene®
software (from GSL Biotech; available at snapgene.com).
4 S. Shastri et al. / Plasmid xxx (2016) xxx–xxxorientations in some plasmid vectors is not possible (see below) and
when used in allelic replacement experiments it can result in impaired
growth of the resultant mutants, presumably due to overexpression of
chromosomal genes located downstream of the integrated cassette
(S.S. andM.S.T., unpublished observations). To circumvent this problem,
wemodiﬁed the TpR cassette by placing the efﬁcient T1 T2 transcription
terminators from the E. coli rrnB ribosomal RNA operon, downstream of
the dfrB2 coding sequence (Brosius, 1984; Orosz et al., 1991). To do this,Please cite this article as: Shastri, S., et al., An efﬁcient system for the genera
Plasmid (2016), http://dx.doi.org/10.1016/j.plasmid.2016.11.002we started with pEA302T, a plasmid into which a 500 bp EcoRI frag-
ment containing the 5S rRNA gene and the T1 T2 terminators was
cloned in order to prevent read through transcription of the replica-
tion region (Amann et al., 1983). A DNA fragment containing only
the rrnB T1 T2 terminators was ampliﬁed using primers that also in-
corporated additional restriction sites at the ﬂanking regions of the
fragment, and was subsequently transferred to pUC18 to give
pUC18Ter.tion ofmarked geneticmutants inmembers of the genus Burkholderia,
5S. Shastri et al. / Plasmid xxx (2016) xxx–xxxThe rrnB terminators (from pUC18Ter) were then fused to the dfrB2
gene (from p34E-Tp) by themegaprimer variation of the SOE PCR tech-
nique (Perrin and Gilliland, 1990), and the amplicon was ligated into
pUC19, giving rise to pUC19TpTer. Although the TpTer DNA fragment
in pUC19TpTer can be transferred as a StuI or NdeI cassette, to increase
its versatility, it was transferred into p34E-Km, substituting for the
KmR cassette. The resultant plasmid, p34E-TpTer, is analogous to
p34E-Tp but has strong transcription termination signals located down-
stream of the dfrB2 gene and includes the addition of NdeI sites in the
ﬂanking MCSs (Fig. 1).
3.2. Construction of allelic replacement vectors, pSHAFT2 and pSHAFT3, for
generation of marked mutants in Burkholderia
We sought to improve upon existing vectors used for allelic replace-
ment in the Bcc. A useful vector for insertional inactivation of chromo-
somal genes with selective markers (usually antibiotic resistance
cassettes) is pSHAFT, an R6K-based suicide plasmid (Fig. 2) (Agnoli et
al., 2006). This vector was derived from the transposon delivery plas-
mid, pUTmini-Tn5Cm (de Lorenzo et al., 1990), by deletion of the tnp
(transposase) gene and one of the 19 bp repeat sequences (the ‘I end’)
that ﬂank mini-Tn5Cm, and therefore it cannot be mobilised in theFig. 2.Maps of the gene replacement vectors of the pSHAFT-series utilised for markedmutagen
resistance) and catA2 (chloramphenicol-resistance), RP4 origin of transfer (oriT), R6K origin of r
(top right), pSHAFT3 (centre right) and pSHAFT-GFP (bottom right). The transcriptional orient
shown. Additional restriction sites in pSHAFT that ﬂank the Ω-Cm interposon (dashed line) ar
Maps created with SnapGene® software (from GSL Biotech; available at snapgene.com).
Please cite this article as: Shastri, S., et al., An efﬁcient system for the genera
Plasmid (2016), http://dx.doi.org/10.1016/j.plasmid.2016.11.002presence of transposase provided in trans. pSHAFT is also devoid of
the pir gene, which speciﬁes the plasmid replication initiator protein,
π, and can therefore only replicate in bacteria containing the pir gene,
such as E. coli CC118(λpir) (Herrero et al., 1990; Rakowski and
Filutowicz, 2013). Along with the chloramphenicol-resistance marker
carried by mini-Tn5Cm, pSHAFT also contains the origin of transfer
(oriT) from RP4 (RK2) that allows for efﬁcient conjugal transfer of the
plasmid to a variety of Gram-negative bacterial species. Following trans-
fer of a Bcc gene (or gene fragment) to pSHAFT, the gene is disrupted by
insertion an antibiotic-resistance cassette (other than CmR) that is se-
lectable in the Bcc. The plasmid is then introduced into a Bcc strain
and selection for the presence of the antibiotic-resistance cassette
(AbR) is applied. As the plasmid cannot replicate in Bcc, only
recombinants are obtained in which the plasmid has recombined with
the host genome at the locus that is homologous to the Bcc DNA present
on the plasmid. Thismay result in integration of the plasmid into the ge-
nome (single crossover, CmR AbR) or allelic replacement (double cross-
over, CmS AbR).
However, themajor drawbackwith pSHAFT is the limited number of
unique restriction sites that can be used for inserting mutant alleles for
subsequent chromosomal targeting. One reason for this is the duplica-
tion of restriction sites either side of the CmR element during theesis in Burkholderia. The location of antibiotic-resistance conferring genes, bla (ampicillin-
eplication (oriR6K) and GFP-encoding gene (gfp) are indicated for pSHAFT, (left), pSHAFT2
ation for each gene and restriction sites within the multiple cloning site of each vector are
e also indicated. Restriction sites that occur only once in each plasmid are shown in bold.
tion ofmarked geneticmutants inmembers of the genus Burkholderia,
Fig. 3. Generation of marked mutants in B. cenocepacia using pSHAFT2 and pSHAFT-GFP
derivatives. (A) ≥1.0 kb of DNA containing the target gene (or gene fragment) is cloned
into a pSHAFT vector and then disrupted by insertion of an antibiotic resistance cassette,
ensuring there is at least 0.5 kb of homology between the cloned DNA target region and
the chromosome on either side of the cassette. Following transfer of the pSHAFT-
derived construct into Burkholderia, double crossover recombinants are selected for
based on their resistance to the antibiotic speciﬁed by the antibiotic resistance cassette,
and either sensitivity to chloramphenicol (pSHAFT2 and pSHAFT3) or the absence of
ﬂuorescence (pSHAFT-GFP). Candidate mutants are then veriﬁed by PCR using primers
that anneal to genomic sequences located either side of the region cloned into the allelic
replacement vector (‘outside’ primers), indicated as OPfor and OPrev. Drawn to scale.
(B) PCR screening of candidate H111-ΔBCAM0195::Tp mutants following allelic
replacement with pSHAFT2-ΔBCAM0195’::Tp. (C) PCR screening of candidate AHA27-
BCAL1709::TpTer mutants following allelic replacement with pSHAFT-GFP-
BCAL1709::TpTer.
6 S. Shastri et al. / Plasmid xxx (2016) xxx–xxxassembly of mini-Tn5Cm in the progenitor plasmid pUT (de Lorenzo
and Timmis, 1994). Moreover, as discussed above, the cassette specify-
ing resistance to chloramphenicol is unnecessarily large, asmini-Tn5Cm
was originally constructed by inserting the ~3.7 kb Ω-Cm interposon
between the 19 bp I and O ends of Tn5 carried by pUT (de Lorenzo et
al., 1990).
To improve the utility of pSHAFT, the vector wasmodiﬁed by replac-
ing the interposon with a much shorter DNA fragment containing the
catA2 gene under control of a synthetic σ70-dependent promoter as
also incorporated in p34E-Cm2, thereby decreasing the plasmid size
from 7.5 to 4.6 kb. The new plasmid, pSHAFT2, contains 11 unique re-
striction sites located downstream of the catA2 gene, one of which
(StuI) allows the cloning of blunt-ended fragments, while the BglII site
can also accommodate BamHI-generated fragments. At the catA2-distal
end of the MCS are three closely spaced EcoRI sites that can be consid-
ered as an additional single unique site for cloning purposes (Fig. 2).
The versatility of pSHAFT2 was then improved by replacing the re-
gion extending from the NotI site in the MCS to the most distant of the
three EcoRI sites by a double-stranded oligonucleotide that contained
internal SpeI and ApaI sites. This also resulted in a net loss of two of
the three EcoRI sites present in pSHAFT2 and removal of the mini-Tn5
O end that originated from the progenitor plasmid of pSHAFT. The
new plasmid, pSHAFT3 (4.5 kb), is shown in Fig. 2.
3.3. Construction of an allelic replacement vector, pSHAFT-GFP, that allows
ﬂuorogenic detection of integration events in Burkholderia species during
generation of marked mutants
To allow for inactivation of chromosomal genes where the
Burkholderia strain already harbours a chloramphenicol resistance
marker or to disrupt chromosomal genes with a CmR cassette we con-
structed pSHAFT-GFP (Fig. 2). This plasmid is analogous to pSHAFT2
but with the catA2 gene replaced by the gfp gene, which therefore al-
lows for ﬂuorogenic detection of recombinants containing the
genomically integrated vector. The forward primer used to amplify the
gfp gene speciﬁed recognition sites for the restriction enzymes SalI,
SmaI, BglII,XbaI,KpnI, XhoI and StuI and an artiﬁcial promoter containing
the consensus−35 and−10 elements for σ70-dependent promoters,
whereas the reverse primer speciﬁed only a BamHI site. This vector is
used in the same way as pSHAFT2 except for the fact that single and
double crossover recombinants harbouring the selectable marker used
to inactivate the target chromosomal gene are distinguished from
each other by screening colonies for the absence of yellow-green ﬂuo-
rescence. Although this usually requires exposure to UV in the dark (a
UV transilluminatorworkswell in this regard), in somemutagenesis ex-
periments the presence of the GFPmarker can be discerned without re-
course to UV exposure by the yellow-green colour of the colonies.
3.4. Isolation ofmarkedmutants in B. cenocepacia and related species using
the pSHAFT-vector series
To inactivate chromosomal genes in Burkholderia using the pSHAFT-
vector series, DNA fragments of ≥1.0 kb containing the target gene (or
gene fragment) are inserted into the MCS and then subsequently
disrupted by insertion of an antibiotic resistance cassette (usually TpR,
KmR or TcR) such that at least 0.5 kb of homology occurs between the
cloned DNA target region and the chromosome either side of the lesion
(Fig. 3A). Depending on the availability of restriction sites, in some cases
we have found it more convenient to ﬁrst clone the target DNA se-
quence into a general-purpose plasmid vector and then introduce the
antibiotic resistance cassette before transferring the disrupted DNA
fragment to the suicide vector. In using these plasmids to inactivate
chromosomal genes in Burkholderia, we have observed that the TpR cas-
sette can often only be inserted into target genes in one orientation,
such that transcription is directed towards the catA2 gene, and away
from the origin of replication. We assume this is due to transcriptionalPlease cite this article as: Shastri, S., et al., An efﬁcient system for the genera
Plasmid (2016), http://dx.doi.org/10.1016/j.plasmid.2016.11.002destabilisation of plasmid replication functions (Gentz et al., 1981;
Stueber and Bujard, 1982; Stassi and Lacks, 1982) as this problem
does not occur with the TpTer cassette (our unpublished observations).
Once the disrupted gene or gene fragment has been introduced into
pSHAFT2, it is transferred to Burkholderia and selection is applied for the
antibiotic resistance marker that was used to disrupt the gene or gene
fragment present in the suicide vector, thus identifying strains that
have integrated the disrupted allele into the genomeby homologous re-
combination. Recombinants are of two types: those that are the result of
a single crossover, in which the entire plasmid has integrated into the
genomeat the target gene locus, and those that are the result of a double
crossover in which only the mutant allele has been transferred to the
genome in place of the original wild type gene (Fig. 3A). In the former,
wild type and mutated copies of the gene (or gene fragment) are pres-
ent in the genome of the recipient bacterium,whichwill also specify in-
creased resistance to chloramphenicol due to the integrated vector.
These are identiﬁed by ‘patching’ out recombinants on LB agar con-
taining 50 μg/ml chloramphenicol. Chloramphenicol-sensitive
recombinants are screened for the presence of the mutated allele
(and absence of the wild type allele) by PCR using primers that an-
neal to genomic sequences ﬂanking the region that was originally
cloned in the suicide vector.
We have successfully used pSHAFT2 to generate severalmarkedmu-
tants within Bcc species. This included the insertional inactivation of the
I35_0520 gene in B. cenocepacia strain H111 (the orthologue oftion ofmarked geneticmutants inmembers of the genus Burkholderia,
7S. Shastri et al. / Plasmid xxx (2016) xxx–xxxBCAM0195 in strain J2315 and will be referred to as such hereon),
which was disrupted by the TpR cassette derived from p34E-Tp.
BCAM0195 is predicted to encode a non-ribosomal peptide synthetase
(NRPS) of unknown function. During the isolation of the
ΔBCAM0195::Tp mutant, we observed that out of 50 trimethoprim re-
sistant exconjugants, 16 were chloramphenicol sensitive. Three of
these were veriﬁed as ΔBCAM0195::Tp mutants by PCR, where the
DNA fragment ampliﬁed from BCAM0195 in the mutants was ~900 bp
smaller than the wild-type, due to replacement of a large segment of
BCAM0195 by the TpR cassette in the ΔBCAM0195::Tp allele (Fig. 3B).
We have also used this plasmid to introduce an orbI::Tp allele into the
genomeof B. lata using the same selection conditions employed for alle-
lic replacement in B. cenocepacia (results not shown). The applicability
of the pSHAFT vectors to other non-Bcc species within the genus was
established by generating a type VI secretion system mutant of B.
thailandensis (a member of the ‘pseudomallei’ group) in an analogous
fashion using pSHAFT3 as the vector and the TpTer cassette to disrupt
the tssK gene (results not shown).
To demonstrate the utility of pSHAFT-GFP it was used to inactivate
the orthologue of the B. cenocepacia J2315 BCAL1709 gene that is
present in the siderophore-negative B. cenocepacia mutant AHA27.
AHA27 is a derivative of B. cenocepacia strain Pc715j that contains
a mini-Tn5CmlacZYA insertion in the pobA gene encoding a
phosphopantetheinyl transferase (PPTase) required for activating
NRPS enzymes, and thereby speciﬁes higher levels of resistance to
chloramphenicol than the parent strain (Asghar et al., 2011). Based on
amino acid sequence alignment, BCAL1709 is very likely to encode a pu-
tative TonB-dependent receptor thought to be involved in the uptake of
an unknown xenosiderophore complexed with ferric iron (M.S.T., un-
published results). Following cloning of a BCAL1709 gene fragment in
pSHAFT-GFP and its disruption with the TpR cassette derived from
p34E-TpTer, the resultant plasmid (pSHAFT-GFP-BCAL1709::TpTer)
was introduced into AHA27 and candidate BCAL1709mutants were se-
lected by screening trimethoprim-resistant exconjugants for the ab-
sence of GFP-mediated ﬂuorescence. Among 50 ex-conjugants that
were screened in this way, 6 non-ﬂuorescent recombinants were iden-
tiﬁed which were subsequently veriﬁed as BCAL1709 mutants by PCR,
as indicated by a ~900 bp increase in the size of the DNA fragment am-
pliﬁed from the BCAL1709 locus due to the presence of the TpR cassette
(Fig. 3C).
It should also be noted that use of the TpR cassette in allelic replace-
ment experiments is also applicable to Burkholderia strains that exhibit
higher levels of intrinsic resistance to trimethoprim, such asmembers of
the B. cenocepacia ET-12 lineage, i.e. strains J2315 and K56-2. Due to the
highly active promoter located upstreamof the dfrB2ORF, expression of
the gene is sufﬁciently strong to allow its selection in such strains by in-
creasing the concentration of trimethoprim in the medium, and we
have used pSHAFT2 to transfer TpR cassette-disrupted iron acquisition
and type VI secretion system genes into K56-2 (unpublished results).
4. Conclusion
To conclude,we have constructed a series of versatile suicide vectors
and antibiotic resistance cassettes that allow for the efﬁcient and simple
generation of marked mutants in Burkholderia species. We have im-
proved upon our original vector pSHAFT by reducing the size of the
CmR marker and increasing the availability of unique restriction site
for cloning in vectors pSHAFT2 and pSHAFT3. The versatility of this plas-
mid series has been further enhanced by incorporating a ﬂuorescent
marker in pSHAFT-GFP to provide an alternative means of
distinguishing recombinants that have undergone allelic replacement
events from those in which the suicide vector remains integrated in
the genome. All vectors described here are a useful addition to the mo-
lecular toolkit required for themanipulation and subsequent character-
ization of important genes in not only Burkholderia species,
but potentially other Proteobacteria, such as enterobacteria andPlease cite this article as: Shastri, S., et al., An efﬁcient system for the genera
Plasmid (2016), http://dx.doi.org/10.1016/j.plasmid.2016.11.002pseudomonads, where they may be used in combination with the anti-
biotic-resistance cassettes described herein or other available antibiot-
ic-resistance markers.
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